Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Lenka Babičková"'
1
P2-213: The 7-years results of the surgical treatment of non-small cell lung cancer patients and the influence of neoadjuvant treatment
Autor: Jana Kaplanová, Irena Vašutová, Ivo Hanke, Pavel Turčáni, Jana Skrickova, Theodor Horváth, Jindrich Vomela, Adam Svobodník, Lenka Babičková, Marcela Tomíšková, Bohdan Kadlec
Publikováno v: Journal of Thoracic Oncology. 2(8)
Results of seven years of surgical treatment of non-small cell lung cancer are presented in this paper. As neoadjuvant treatment was also performed in this group of patients, its influence on the overall outcome could be evaluated.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf2a4b38069bf9cbe73ad16f1c4a41a
Zobrazit plný text záznamu
2
59P MARKERS OF PROLIFERATION ACTIVITY IN NON-SMALL CELL LUNG CANCER
Autor: K. Chroust, Bohdan Kadlec, Marcela Tomíšková, L. Kren, Z. Pavlovsky, I. Vasutova, Jana Skrickova, Y. Stankova, Lenka Babičková
Publikováno v: Lung Cancer. 64:S30-S31
A variety of parameters acknowledged to be markers of proliferation activity of non-small cell lung cancer were followed up and discussed in this paper.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0fbd7238ac2d454251a9b6bae9c0d197
https://doi.org/10.1016/s0169-5002(09)70182-5
Zobrazit plný text záznamu
3
Full Oral Vinorelbine (NVBO) on D1 and D8 With Carboplatin (CBDCA) as First Line Treatment in Advanced Non-small Cell Lung Cancer (NSCLC) Patients: Preliminary Results of a Prospective Sudy in Nonrandomized Population
Autor: Vitezslav Kolek, Lenka Babičková, T. Janásková, Marcela Tomíšková, Jaromír Roubec, Jana Skrickova, Ivona Grygárková
Publikováno v: Chest. 140:956A
The purpose of this trial was to evaluate the activity and feasibility of CBDCA together with NVBO as first line treatment in patients with advanced NSCLC. METHODS: Patients with advanced NSCLC received NVBO 80 mg/m2 on D1 and D8 with CBDCA AUC5 on D
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2011dbca0952a25b912986b42f05dc16
https://doi.org/10.1378/chest.1103753
Zobrazit plný text záznamu
4
Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first-line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonselected population
Autor: Jana Skrickova, Bohdan Kadlec, Lenka Babičková, Marcela Tomíšková
Publikováno v: Journal of Clinical Oncology. 28:e18061-e18061
The use of intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first-line treatment in advanced non-small lung cancer (NSCLC) patients: results of a prospective study in nonselected popul
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::120854b09cd6fcba6aa9f23730b3d8be
https://doi.org/10.1200/jco.2010.28.15_suppl.e18061
Zobrazit plný text záznamu
8
P-55 Chemotherapy with ifosfamide and concomitant radiotherapy in limited disease (LD) small cell lung cancer (SCLC)
Autor: Jana Koptíková, Olga Kubová, Ivana Pálková, Adam Svobodník, Lenka Babičková, Jana Kaplanová, Marcela Tomíšková, Jana Skrickova
Publikováno v: Lung Cancer. 41:S104
A restrospective study of 115 consecutive pts. with limited SCLC was aimed at therapeutic results and toxicity. From preliminary results authors conclude that the use of IFO/CBDCA/VP16 with concomitant raditherapy is an effective therapy, radiotherap
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::37266d2c1c37b14360ed215d9761545a
https://doi.org/10.1016/s0169-5002(03)92024-1
Zobrazit plný text záznamu
9
P-703 A realistic view of the surgical treatment in patients with non-small cell lung cancer (NSCLC): An analysis of 248 patients
Autor: Olga Kubová, Jana Skrickova, Tomas Nebesky, Adam Svobodník, Jana Kaplanová, Jindrich Vomela, Ivo Hanke, Jana Koptíková, Theodor Horváth, Lenka Babičková
Publikováno v: Lung Cancer. 41:S269
248 patients with primary NSCL were analyzed; 29% of them underwent radical resection. The results so far show a better survival for pts. with radical resection compared with pts. with neoadjuvant therapy, but the study is sill in progress.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::147475021d7003c3bffbe95d75052499
https://doi.org/10.1016/s0169-5002(03)92670-5
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje